Cited by 251Occupational and environmental lung diseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational Health and Global Justice

Asbestos-induced lung diseases: an update

Open access
Kamp, David W.·2009·Translational Research

Abstract

Asbestos causes asbestosis (pulmonary fibrosis caused by asbestos inhalation) and malignancies (bronchogenic carcinoma and mesothelioma) by mechanisms that are not fully elucidated. Despite a dramatic reduction in asbestos use worldwide, asbestos-induced lung diseases remain a substantial health concern primarily because of the vast amounts of fibers that have been mined, processed, and used during the 20th century combined with the long latency period of up to 40 years between exposure and disease presentation. This review summarizes the important new epidemiologic and pathogenic information that has emerged over the past several years. Whereas the development of asbestosis is directly associated with the magnitude and duration of asbestos exposure, the development of a malignant clone of cells can occur in the setting of low-level asbestos exposure. Emphasis is placed on the recent epidemiologic investigations that explore the malignancy risk that occurs from nonoccupational, environmental asbestos exposure. Accumulating studies are shedding light on novel mechanistic pathways by which asbestos damages the lung. Attention is focused on the importance of alveolar epithelial cell (AEC) injury and repair, the role of iron-derived reactive oxygen species (ROS), and apoptosis by the p53- and mitochondria-regulated death pathways. Furthermore, recent evidence underscores crucial roles for specific cellular signaling pathways that regulate the production of cytokines and growth factors. An evolving role for epithelial-mesenchymal transition (EMT) is also reviewed. The translational significance of these studies is evident in providing the molecular basis for developing novel therapeutic strategies for asbestos-related lung diseases and, importantly, other pulmonary diseases, such as interstitial pulmonary fibrosis and lung cancer.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.trsl.2009.01.004

Cites

109 of 109 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 111 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

  1. [17]World Health Organization Summary consensus report of WHO workshop on mechanisms of fibre carcinogenesis and assessment of chrysotile asbestos substitutes Lyon France World Health Organization Nov-Dec 2005
  2. [25]Miller A Lilis R Godbold J Chan E Selikoff IJ Relationship of pulmonary function to radiographic interstitial fibrosis in 2,611 long-term asbestos insulators Am Rev Respir Dis 1992 145 263 70 1736729
  3. [44]Gibbs A Attanoos RL Churg A Weill H The “Helsinki Criteria” for attribution of lung cancer to asbestos exposure Arch Pathol Lab Med 2007 131 181 84 17284100

Cited by

Sorted by citations

Authors
Kamp, D. W.
Affiliations
Northwestern University (US)
Corresponding author
Kamp, David W.
Venue
Translational Research
Publisher
Elsevier BV
Published
2009-04
Volume
153
Issue
4
Pages
143-152
ISSN
  • 1878-1810 (ISSN-L)
  • 1931-5244
OpenAlex
W2115450306
Cited by
251
References
111
Citations by year
2026: 4 · 2025: 12 · 2024: 11 · 2023: 17 · 2022: 9 · 2021: 17 · 2020: 12 · 2019: 12 · 2018: 10 · 2017: 11 · 2016: 6 · 2015: 15 · 2014: 22 · 2013: 27 · 2012: 22
FWCI
3.27
Type
journal article
Language
en
Open access
Locations
  • Translational research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01HL035440)
  • National Institute of Environmental Health Sciences (R01ES013995)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Social Sciences › Health › Occupational Health and Global Justice
Keywords
asbestos, asbestosis, pulmonary fibrosis, mesothelioma, lung cancer, asbestos exposure, environmental asbestos exposure, alveolar epithelial cells, reactive oxygen species, iron, apoptosis, p53, mitochondrial apoptosis, cytokines, growth factors, epithelial-mesenchymal transition, interstitial pulmonary fibrosis, latency period, pathogenesis
MeSH terms
Asbestos, Humans, Lung Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review